Evolving patterns in a collaboration network of global R&D on monoclonal antibodies

References

• Staropoli C. Cooperation in R&D in the pharmaceutical industry – The network as an organizational innovation governing technological innovation. Technovation. 1998; 18(1):13-23. doi:10.1016/S0166-4972(97)00107-7
   Web of Science ®Google Scholar
• Tushman ML, Anderson P. Technological discontinuities and organizational environments. Admin Sci Quart. 1986; 31(3):439-65. doi:10.2307/2392832
   Web of Science ®Google Scholar
• Malerba F, Orsenigo L. The evolution of the pharmaceutical industry. Bus Hist. 2015; 57(5):664-87. doi:10.1080/00076791.2014.975119
   Web of Science ®Google Scholar
• Teece DJ. Competition, cooperation, and innovation. J Econ Behav Organ. 1992; 18(1):1-25. doi:10.1016/0167-2681(92)90050-L
   Web of Science ®Google Scholar
• Hunter J, Stephens S. Is open innovation the way forward for big pharma? Nat Rev Drug Discov. 2010; 9:87-8. doi:10.1038/nrd3099
   Web of Science ®Google Scholar
• Ni J, Wan J, Kong X, Cai Y, Yang F, Wang Y, Hu Y. Pharmaceutical technology licensing: An analysis in the field of cardiovascular disease. J Pharm Innov. 2016; 11(1):34-45. doi:10.1007/s12247-015-9234-5
   Web of Science ®Google Scholar
• Powell WW. Learning from collaboration: Knowledge and networks in the biotechnology and pharmaceutical industries. Calif Manage Rev. 1998; 40(3):228-40. doi:10.2307/41165952
   Web of Science ®Google Scholar
• Belderbos R, Carree M, Lokshin B, Sastre JF. Inter-temporal patterns of R&D collaboration and innovative performance. J Technol Transf. 2015; 40:123-37. doi:10.1007/s10961-014-9332-4
   Web of Science ®Google Scholar
• Powell WW, Koput KW, Smith-Doerr L. Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology. Admin Sci Quart. 1996; 41(1):116-45. doi:10.2307/2393988
   Web of Science ®Google Scholar
• Hoang H, Antoncic B. Network-based research in entrepreneurship: A critical review. J Bus Venturing. 2003; 18(2):165-87. doi:10.1016/S0883-9026(02)00081-2
   Web of Science ®Google Scholar
• Powell WW, White DR, Koput KW, Owen-Smith J. Network dynamics and field evolution: The growth of interorganizational collaboration in the life sciences. Am J Sociol. 2005; 110(4):1132-205. doi:10.1086/421508
   Web of Science ®Google Scholar
• Zaheer A, Gözübüyük R, Milanov H. It's the connections: The network perspective in interorganizational research. Acad Manage Perspect. 2010; 24(1):62-77. doi:10.5465/AMP.2010.50304417
   Web of Science ®Google Scholar
• Brass DJ, Galaskiewicz J, Greve HR, Tsai W. Taking stock of networks and organizations: a multilevel perspective. Acad Manage J. 2004; 47(6):795-817; doi:10.2307/20159624
   Web of Science ®Google Scholar
• Borgatti SP, Foster PC. The network paradigm in organizational research: A review and typology. J Manage. 2003; 29(6):991-1013. doi:10.1016/S0149-2063(03)00087-4
   Web of Science ®Google Scholar
• Bergenholtz C, Waldstrøm C. Inter-organizational network studies—A literature review. Ind Innov. 2011; 18(6):539-62. doi:10.1080/13662716.2011.591966
   Web of Science ®Google Scholar
• Provan KG, Fish A, Sydow J. Interorganizational networks at the network level: A review of the empirical literature on whole networks. J Manage. 2007; 33(3):479-516. doi:10.1177/0149206307302554
   Web of Science ®Google Scholar
• McKelvey M, Rake B. Product innovation success based on cancer research in the pharmaceutical industry: co-publication networks and the effects of partners. Ind Innov. 2016; 23(5):383-406. doi:10.1080/13662716.2016.1150157
   Web of Science ®Google Scholar
• Knoben J, Oerlemans LAG, Rutten RPJH. Radical changes in inter-organizational network structures: The longitudinal gap. Technol Forecast Soc. 2006; 73(4):390-404. doi:10.1016/j.techfore.2005.05.010
   Web of Science ®Google Scholar
• Powell WW, Koput KW, Smith-Doerr L, Owen-Smith J. Network position and firm performance: organizational returns to collaboration in the biotechnology industry. Res Sociol Organizations. Greenwich, CT: JAI Press 1999; 16:129-59
   Google Scholar
• Koka BR, Prescott JE. Designing alliance networks: the influence of network position, environmental change, and strategy on firm performance. Strategic Manage J. 2008; 29(6):639-61. doi:10.1002/smj.679
   Web of Science ®Google Scholar
• Roijakkers N, Hagedoorn J. Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks. Res Policy. 2006; 35(3):431-46. doi:10.1016/j.respol.2006.01.006
   Web of Science ®Google Scholar
• Li J, Zhu Z. Research and development of next generation of antibody-based therapeutics. Acta Pharmacol Sin. 2010; 31:1198-207. doi:10.1038/aps.2010.120. PMID:20694021
   PubMed Web of Science ®Google Scholar
• Munro TP, Mahler SM, Huang EP, Chin DY, Gray PP. Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidates. mAbs. 2011; 3(5):440-52. doi:10.4161/mabs.3.5.16968. PMID:21822050
   PubMed Web of Science ®Google Scholar
• Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov. 2010; 9(10):767-74. doi:10.1038/nrd3229. PMID:20811384
   PubMed Web of Science ®Google Scholar
• Ecker DM, Jones SD, Levine HL. The therapeutic monoclonal antibody market. mAbs. 2015; 7(1):9-14. doi:10.4161/19420862.2015.989042. PMID:25529996
   PubMed Web of Science ®Google Scholar
• Gay B, Dousset B. Innovation and network structural dynamics: Study of the alliance network of a major sector of the biotechnology industry. Res Policy. 2005; 34(10):1457-75. doi:10.1016/j.respol.2005.07.001
   Web of Science ®Google Scholar
• Geng X, Kong X, Hu H, Chen J, Yang F, Liang H, Chen X, Hu Y. Research and development of therapeutic mAbs: An analysis based on pipeline projects. Hum Vaccin Immunother. 2015; 11(12):2769-76. doi:10.1080/21645515.2015.1074362. PMID:26211701
   PubMed Web of Science ®Google Scholar
• Petering J, McManamny P, Honeyman J. Antibody therapeutics - the evolving patent landscape. N Biotechnol. 2011; 28(5):538-44. doi:10.1016/j.nbt.2011.03.023. PMID:21515427
   PubMed Web of Science ®Google Scholar
• Gulati R. Social structure and alliance formation patterns: a longitudinal analysis. Admin Sci Quart. 1995; 40(4):619-52. doi:10.2307/2393756.
   Web of Science ®Google Scholar
• McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 1990; 348(6301):552-4. doi:10.1038/348552a0. PMID:2247164
   PubMed Web of Science ®Google Scholar
• Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, McCafferty J, Hodits RA, Wilton J, Johnson KS. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol. 1996; 14(3):309-14. doi:10.1038/nbt0396-309. PMID:9630891
   PubMed Web of Science ®Google Scholar
• Christensen CM, Rosenbloom RS. Explaining the attacker's advantage: technological paradigms, organizational dynamics, and the value network. Res Policy. 1995; 24(2):233-57. doi:10.1016/0048-7333(93)00764-K
   Web of Science ®Google Scholar
• Berchicci L. Towards an open R& D system: internal R&D investment, external knowledge acquisition and innovative performance. Res Policy. 2013; 42(1):117-27. doi:10.1016/j.respol.2012.04.017
   Web of Science ®Google Scholar
• Rigby D, Zook C. Open-market innovation. Harv Bus Rev. 2002; 80(10):80-9. PMID:12389463
   PubMed Web of Science ®Google Scholar
• Albert R, Jeong H, Barabási AL. Internet: diameter of the World-Wide Web. Nature. 1999; 401:130-1; doi:10.1038/43601
   Web of Science ®Google Scholar
• Jeong H, Tombor B, Albert R, Oltvai ZN, Barabási AL. The large-scale organization of metabolic networks. Nature. 2000; 407:651-4; doi:10.1038/35036627. PMID:11034217
   PubMed Web of Science ®Google Scholar
• Barabási AL, Jeong H, Néda Z, Ravasz E, Schubert A, Vicsek T. Evolution of the social network of scientific collaborations. Physica A. 2002; 311(3–4):590-614. doi:10.1016/S0378-4371(02)00736-7
   Web of Science ®Google Scholar
• Barabási AL, Albert R. Emergence of scaling in random networks. Science. 1999; 286(5439):509-12. doi:10.1126/science.286.5439.509. PMID:10521342
   PubMed Web of Science ®Google Scholar
• Bianconi G, Barabási AL. Competition and multiscaling in evolving networks. Europhys Lett. 2001; 54(4):436-42. doi:10.1209/epl/i2001-00260-6.
   Google Scholar
• Freeman C. The economics of technical change. Cambridge J Econ. 1994; 18(5):463-514. doi:10.1093/oxfordjournals.cje.a035286
   Web of Science ®Google Scholar
• Hagedoorn J. Strategic technology partnering during the 1980s: Trends, networks and corporate patterns in non-core technologies. Res Policy. 1995; 24(2):207-31. doi:10.1016/0048-7333(94)00763-W
   Web of Science ®Google Scholar
• Tripsas M. Unraveling the process of creative destruction: complementary assets and incumbent survival in the typesetter industry. Strategic Manage J. 1997; 18(1):119-42. doi:10.1002/(SICI)1097-0266(199707)18:1+3.3.CO;2-S
   Google Scholar
• Schumpeter J. The theory of economic development: An inquiry into profits, capital, credit, interest, and the business cycle. London: Transactions Publishers; 1934
   Google Scholar
• Cohen WM, Levinthal DA. Absorptive capacity: A new perspective on learning and innovation. Admin Sci Quart. 1990; 35(1):128-52. doi:10.2307/2393553
   Web of Science ®Google Scholar
• West J, Bogers M. Leveraging external sources of innovation: A review of research on open innovation. J Prod Innovat Manag. 2014; 31(4):814-31. doi:10.1111/jpim.12125
   Web of Science ®Google Scholar
• Gautam A, Pan X. The changing model of big pharma: Impact of key trends. Drug Discov Today. 2016; 21(3):379-84. doi:10.1016/j.drudis.2015.10.002. PMID:26477304
   PubMed Web of Science ®Google Scholar
• Newman MEJ. The structure of scientific collaboration networks. Proc Natl Acad Sci U S A. 2001; 98(2):404-9. doi:10.1073/pnas.98.2.404. PMID:11149952
   PubMed Web of Science ®Google Scholar
• Liu X, Bollen J, Nelson ML, Van de Sompel H. Co-authorship networks in the digital library research community. Inform Process Manag. 2005; 41(6):1462-80. doi:10.1016/j.ipm.2005.03.012
   Web of Science ®Google Scholar
• Khan GF, Park HW. The e-government research domain: A triple helix network analysis of collaboration at the regional, country, and institutional levels. Gov Inform Q. 2013; 30(2):182-93. doi:10.1016/j.giq.2012.09.003
   Web of Science ®Google Scholar
• You H, Ni J, Barber M, Scherngell T, Hu Y. China's landscape in oncology drug research: perspectives from research collaboration networks. Chin J Cancer Res. 2015; 27(2):138-47. doi:10.3978/j.issn.1000-9604.2015.04.05. PMID:25937775
   PubMed Web of Science ®Google Scholar